The U.S. Food and Drug Administration has opened a public docket requesting stakeholder feedback on the cybersecurity risks associated with autonomous and remotely operated medical devices. This is not a routine regulatory exercise. It signals that the FDA sees the convergence of autonomy, teleoperation, and networked medical technology as an emerging threat surface that current guidance does not adequately address — and that mandatory requirements are likely on the horizon.
For healthcare delivery organizations (HDOs), biomedical engineering teams, and security operations centers, this is an early warning. The devices entering clinical environments today — surgical robots, remotely operated imaging platforms, autonomous infusion systems, and telepresence units — carry attack surfaces that most hospital security architectures were never designed to defend. The time to act is now, before a device in your facility becomes the pivot point for the next healthcare breach headline.
Understanding the Threat Landscape
Autonomous and remotely operated medical devices represent a fundamental shift in how clinical care is delivered. Unlike traditional networked medical devices that primarily transmit data, these systems accept real-time commands from remote operators, execute physical actions autonomously, and often integrate with hospital networks, cloud platforms, and external operator consoles simultaneously.
The attack surface spans multiple domains:
- Network communication channels — Teleoperated devices rely on real-time, low-latency network connections between the device and the operator's console. These connections may traverse hospital LANs, WAN links, VPN tunnels, or public internet infrastructure. Any interception, manipulation, or denial of service on these channels has direct patient safety implications.
- Authentication and authorization mechanisms — Remote operation demands robust identity verification for operators, yet many current-generation devices rely on legacy authentication schemes, shared credentials, or insufficiently hardened session management.
- Software supply chain — These devices are complex systems built on commercial operating systems, open-source libraries, and third-party communication stacks. A vulnerability in any dependency — an embedded Linux kernel, an outdated TLS library, a vulnerable communication protocol — becomes a vulnerability in the medical device itself.
- Physical and environmental access — Autonomous devices operating in clinical settings interact with patients, staff, and the physical environment. Compromised autonomy algorithms or manipulated sensor inputs could cause physical harm without any traditional network intrusion indicators.
- Firmware and update mechanisms — Over-the-air update capabilities, while necessary for patching, create an attack vector if update servers, signing keys, or delivery pipelines are compromised.
The FDA's request for feedback specifically targets these areas, asking stakeholders to describe risks they have observed, mitigations they have implemented, and gaps in current guidance. The agency is not asking whether these risks exist — it is asking how severe they are and what should be done about them.
Why This Matters Now
The timing of this request is not coincidental. Healthcare remains the most targeted sector for ransomware attacks, with HDOs experiencing sustained, high-impact campaigns from threat actors who understand that operational disruption in healthcare creates maximum pressure to pay. The 2024 Change Healthcare ransomware attack demonstrated how a single compromised system can cascade across the entire U.S. healthcare ecosystem, disrupting claims processing, pharmacy operations, and clinical workflows for months.
Autonomous and remotely operated devices amplify this risk. A compromised surgical robot or remotely operated imaging system does not just threaten data confidentiality — it threatens patient lives. This elevates the stakes from a HIPAA breach notification scenario to a patient safety event with regulatory, legal, and reputational consequences that no HDO can absorb.
The FDA already requires premarket cybersecurity documentation for medical device submissions under its 2023 guidance, and Section 3305 of the Consolidated Appropriations Act of 2023 gave the agency explicit statutory authority to enforce cybersecurity requirements. This new request for feedback on autonomous and teleoperated devices signals that the agency is preparing to extend and deepen these requirements for a device category that current guidance does not fully cover.
For security teams, this means that regulatory pressure is coming. The organizations that begin building defensive capabilities now — inventorying devices, segmenting networks, establishing monitoring baselines, and engaging with manufacturers — will be positioned to comply when requirements arrive. Those that wait will be scrambling to retrofit security onto devices that are already in clinical use.
Detection and Response Considerations
This is a policy and risk advisory, not a vulnerability disclosure with specific IOCs or CVEs. The FDA is requesting input, not alerting to an active exploitation campaign. However, the defensive actions required are concrete and actionable. Security teams should treat this as a strategic intelligence trigger and begin implementing the following capabilities.
Executive Takeaways
-
Inventory all autonomous and remotely operated medical devices in your environment. Work with biomedical engineering, clinical engineering, and procurement to build a comprehensive asset inventory that includes device make, model, firmware version, network connectivity, communication protocols, and remote access capabilities. You cannot defend what you do not know you have. This inventory should be integrated into your CMDB and updated continuously as new devices are deployed.
-
Segment medical device networks aggressively. Autonomous and teleoperated devices should reside on dedicated, micro-segmented VLANs with strict access control lists. Traffic between the device network and the rest of the hospital network should be mediated by a firewall with application-layer inspection. East-west traffic between medical devices should be denied by default and explicitly permitted only where clinical workflows require it. If a device communicates with an external operator console or cloud service, that connection should traverse a dedicated, monitored channel — not the general hospital internet connection.
-
Establish behavioral baselines for device network traffic. Teleoperated devices generate predictable communication patterns — specific ports, protocols, destinations, and data volumes. Deploy network detection and response (NDR) capabilities that baseline this behavior and alert on deviations. An autonomous infusion pump that suddenly begins communicating with an unfamiliar external IP address, or a surgical robot that generates unexpected outbound DNS queries, should trigger immediate investigation.
-
Engage manufacturers on security architecture now. Use the FDA's request for feedback as leverage. Contact the manufacturers of every autonomous and remotely operated device in your inventory and request their cybersecurity documentation — threat models, software bills of materials (SBOMs), patch management policies, vulnerability disclosure programs, and incident response procedures. If a manufacturer cannot provide this information, escalate the concern through procurement and clinical leadership. The FDA's eventual requirements will hold manufacturers accountable, but HDOs cannot afford to wait for that accountability to materialize.
-
Integrate medical device security into your IR plan. Your incident response plan must include specific playbooks for medical device compromise. These playbooks should address the unique challenges of medical device IR — the inability to simply take a device offline if it is actively supporting patient care, the need for clinical engineering involvement in forensic acquisition, the regulatory reporting obligations under HIPAA and FDA postmarket requirements, and the coordination with device manufacturers who may hold proprietary diagnostic tools and firmware access. Run tabletop exercises that simulate a compromised teleoperated device scenario. The first time your IR team encounters this scenario should not be during a live incident.
-
Monitor for anomalous authentication and session activity. Remote operation requires remote authentication. Implement strong authentication for all remote access to medical devices — multi-factor authentication, certificate-based authentication, or hardware tokens. Monitor for anomalous authentication patterns: logins from unexpected geographic locations, concurrent sessions from multiple locations, authentication attempts outside of scheduled maintenance windows, and privilege escalation within device management interfaces. These are the indicators that precede compromise.
Broader Strategic Context
The FDA's request for feedback is one signal in a broader pattern. CISA has been expanding its focus on healthcare critical infrastructure, the HHS 405(d) program has published healthcare-specific cybersecurity guidance, and the proposed HIPAA Security Rule update — expected to mandate specific technical controls including network segmentation, encryption, and multi-factor authentication — will directly impact how HDOs secure connected medical devices.
The convergence of these regulatory pressures means that medical device cybersecurity is no longer optional. It is becoming a compliance requirement with enforcement teeth. HDOs that treat this as a future problem will find themselves facing regulatory penalties, cyber insurance exclusions, and — worst of all — patient safety incidents that could have been prevented.
The window for proactive action is open. The FDA is asking for input, which means the specific requirements are still being shaped. Participate in the public comment process. Share your operational experiences, your security challenges, and your defensive requirements. The regulatory framework that emerges will be more practical and more effective if it is informed by the security professionals who are defending these environments every day.
Related Resources
Security Arsenal Healthcare Cybersecurity AlertMonitor Platform Book a SOC Assessment healthcare Intel Hub
Is your security operations ready?
Get a free SOC assessment or see how AlertMonitor cuts through alert noise with automated triage.